Related Experiment Video
Updated: Jun 27, 2026
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
The prognostic role of iron deficiency in acute ischemic stroke patients: A prospective multicentric cohort study
Antonio Ciacciarelli1, Anne Falcou1, Ettore Nicolini1
1Emergency Department, Stroke Unit, Sapienza University of Rome, Rome, Italy.
Insights
Iron deficiency (ID) significantly impacts recovery in acute ischemic stroke patients, predicting poorer functional outcomes at 90 days. This finding highlights the need to investigate iron supplementation as a potential treatment strategy.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Hematology
Background:
- Iron deficiency (ID) is a known prognostic factor in heart failure and acute coronary syndrome.
- Its role in cerebrovascular diseases remains controversial.
- This study investigates the impact of ID on acute ischemic stroke patient outcomes.
Purpose of the Study:
- To determine the association between iron deficiency and functional outcomes in patients with acute ischemic stroke.
- To assess if ID is an independent predictor of poor functional recovery post-stroke.
Main Methods:
- Prospective, multicenter observational cohort study.
- Enrolled 442 acute ischemic stroke patients from January to December 2023.
- Defined ID using serum ferritin and transferrin saturation; assessed functional outcome at 90 days using modified Rankin Scale (mRS).
Main Results:
- Prevalence of iron deficiency was 65.6% in the study population.
- ID was strongly associated with poor functional outcome (mRS 3-6) at 90 days (aOR 2.328, p=0.006).
- This association remained significant after adjusting for multiple confounding factors.
Conclusions:
- Iron deficiency is a significant predictor of poor functional outcome in acute ischemic stroke patients.
- Further research is warranted to explore iron supplementation as a therapeutic strategy to improve stroke recovery.
Background And Aims:
Iron deficiency (ID) is a prognostic factor in heart failure and acute coronary syndrome. However, its role in cerebrovascular diseases is controversial. We aimed to determine the impact of ID on the functional outcome of acute ischemic stroke patients.
Methods:
This was an observational prospective multicentric cohort study. From January to December 2023, we enrolled acute ischemic stroke patients admitted to the stroke units of four comprehensive stroke centers. Venous blood samples were collected at admission to determine the iron status (serum iron, ferritin, transferrin). ID was defined as a serum ferritin concentration < 100 ng/mL or 100-299 ng/mL with transferrin saturation (TSAT) <20 %. The primary endpoint was the poor functional outcome at 90 days defined as modified Rankin Scale (mRS) 3-6. We used binary logistic regression models including confounding factors to test the association between ID and the primary outcome.
Results:
The analysis included 442 patients (mean age 73 ± 13, 47.5 % female, median NIHSS 7 [IQR 3-15], 61.3 % treated with intravenous thrombolysis and/or endovascular treatment). ID prevalence was 65.6 %. In all binary logistic regression models, ID predicted poor functional outcome at 3 months irrespective from demographics, stroke severity and characteristics, anemia, risk factors, signs/symptoms of heart failure, glucose at admission, and inflammatory biomarkers (aOR 2.328, 95 % CI 1.272-4.263, p = 0.006).
Conclusions:
ID was strongly associated with poor functional outcome at 90 days in acute ischemic stroke patients. Further research is required to explore whether iron supplementation could be a potential therapeutic strategy to improve patient outcomes.
